The Trendlines Group

SINGAPORE (Apr 9): The Trendlines Group has revealed that colostomy-device company Stimatix GI is its “Most Valuable Portfolio" company.

SINGAPORE (Mar 21): The Trendlines Group has signed a memorandum of understanding (MoU) with Nutreco NuFrontiers, the strategic innovation and investment division of Netherlands-based Nutreco Investments BV, which produces animal nutrition and aquafeed.

SINGAPORE (Feb 22): Trendlines Group, the investment and innovation commercialisation company, reported earnings of US$3.9 million ($5.2 million) compared to a loss of US$6.6 million a year ago,

SINGAPORE (Jan 4): STS Medical, a portfolio company of The Trendlines Group, has received regulatory clearance from the US Food and Drug Administration (FDA) for its composite sinus stent which is designed to reduce the probability of revision surgeries a

SINGAPORE (Dec 4): Magdent, a portfolio company of The Trendlines Group, completed an investment of US$1.75 million ($2.36 million) from three angel investors.

SINGAPORE (Nov 27): AquiNovo, a portfolio company of The Trendlines Group, has clinched an investment of US$1.5 million ($2 million) from Neovia.

SINGAPORE (Nov 9): The Trendlines Group saw its earnings for 3Q17 nearly double to US$3 million ($4.1 million) from US$1.6 million a year ago on higher total income due to fair value gains.

SINGAPORE (Oct 2): Vensica Medical, a portfolio company of The Trendlines Group, has received a US$2 million ($2.7 million) investment from NASDAQ-listed Cogentix Medical.

SINGAPORE (Sept 25): Fidmi Medical, a portfolio company of The Trendlines Group, has received an investment of US$2 million ($2.7 million) from B. Braun Melsungen AG.

SINGAPORE (Sept 18): The Trendlines Group has signed a memorandum of understanding with Haier Group Corporation subsidiary Haier Hai Chuanghui Incubator and Ventures to collaborate in investment opportunities and technology development.